Jacobus van der Velden

13PUBLICATIONS
53CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersOncology and carcinogenesis not elsewhere classifiedImmunogenetics (incl. genetic immunology)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Jun 26, 2025
Adjuvant Chemoradiotherapy or Radiotherapy Alone for Early Squamous Cervical Cancer with a Single Surgical-Pathological High-Risk Factor.

Ester P Olthof, Hans H B Wenzel, Jacobus van der Velden

|Apr 01, 2025
Radical hysterectomy or chemoradiotherapy for clinically early-stage cervical cancer with suspicious lymph nodes on imaging: a retrospective cohort study.

Ester P Olthof, Hans H B Wenzel, Marissa C van Maaren

|Jan 11, 2025
Impact of the Number of Positive Pelvic Lymph Nodes on Risk of Para-Aortic Recurrence in Patients with Clinically Early Cervical Cancer Treated by a Radical Hysterectomy and Pelvic Lymphadenectomy.

Felix J M Schoonhoven, Johanna W M Aarts, Guus Fons

|Feb 10, 2024
Survival of Women with Advanced Stage Cervical Cancer: Neo-Adjuvant Chemotherapy Followed by Radiotherapy and Hyperthermia versus Chemoradiotherapy.

Jonathan Servayge, Ester P Olthof, Constantijne H Mom

|Sep 01, 2023
Randomized Phase III Study Comparing Neoadjuvant Chemotherapy Followed by Surgery Versus Chemoradiation in Stage IB2-IIB Cervical Cancer: EORTC-55994.

Gemma G Kenter, Stefano Greggi, Ignace Vergote

|Aug 12, 2023
Selective Removal of Only Clinically Suspicious Positive Lymph Nodes Instead of a Complete Inguino-Femoral Lymph Node Dissection in Squamous Cell Carcinoma of the Vulva.

Guus Fons, Nikki B Thuijs, Ming Tjiong

Pageof 3

Frequent Collaborators

5 joint publications

Constantijne H Mom

4 joint publications

Ester Paulien Olthof

3 joint publications

Hans Wenzel

2 joint publications

Helena C van Doorn